Antibodies US 2023 Post-event Report - Antibodies US 2023 Post-event Report (Gated)

<p>Antibodies US 2023 Post-event Report</p><p>San Diego, CA<br>13 - 16 December 2023</p>Welcome to the post-event wrap-up of the 34th annual Antibody Engineering & Therapeutics US 2023 conference, recognized for being the leading knowledge and networking hub in the antibody industry. From December 13 – 16, 2023, more than 900...Contents

<p>Introduction</p>

<p>Tackling Tough Targets in Antibody Discovery by Leveraging a Diverse Suite of In Vivo Discovery Platforms</p>

<p>Accelerating Early Discovery Through HTP and High-Speed Antibody Production</p>

<p>Democratizing Access to Broad B Cell Diversity for Rapid Monoclonal Antibody Discovery from Humans and Beyond</p>

<p><span class="">Accelerating Chimeric Antigen Receptor Discovery: From Targets to Leads with ProCAR™ Platform</span></p>

<p><span class="">Human Antibody Responses to Infection and Vaccination</span></p>

<p>Enhance and Expand Anti-ID Antibody Diversity and Affinity Through Genetic Immunization</p>

<p>ALTHEA Libraries: Phage Display Libraries for Antibody Therapeutic Discovery and Development</p>

<p>Transgenic Chickens Producing Human Heavy Chain-only Antibodies Demonstrate Robust Immune Repertoires and High-affinity Binding</p>

<p><span class="">Xencor’s 20 Year Journey in Antibody Therapeutic Development</span></p>

<p>Efficient Therapeutic Development Using The Pfenex Expression Technology® Platform</p>

<p>Software at Every Stage: Achieving Antibody Discovery at Scale</p>

<p>How to Use Display Technologies to Discover Therapeutic Proteins Against Challenging Targets</p>

<p><span class="">Evolution of Stromal Niches in Inflammation, Cancer and Immunotherapy</span></p>

<p>Exhibitor Spotlight</p>

Read more of our industry reports online!